AbbVie Inc. (ABBV) vs PFIZER INC(PFE)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | ABBV | PFE |
|---|---|---|
| Sector | Health Care | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $61.16B | $62.58B |
| Revenue growth (YoY) | ▲ 8.6% | ▼ 1.6% |
| Net income | $4.23B | $7.81B |
| Gross margin | — | — |
| Diluted EPS | $2.36 | $1.36 |
| Insider net (6 mo) | −11.6K sh · 3 sells · 0 buys | +130.5K sh · 2 sells · 3 buys |
| Institutional owners | 46 | 44 |
| Institutional value held | $222.87B | $61.93B |
| Next earnings (est.) | Around Oct 30, 2026 | Nov 3, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About AbbVie Inc. (ABBV)
AbbVie Inc., incorporated in Delaware in 2012, is a global, diversified research-based biopharmaceutical company that became an independent, publicly-traded entity on January 1, 2013, following its spin-off from Abbott Laboratories.
About PFIZER INC (PFE)
Pfizer Inc. is a research-based, global biopharmaceutical company incorporated in Delaware in 1942 that applies science and global resources to discover, develop, manufacture, market, sell and distribute biopharmaceutical products worldwide, operating across b
Source: SEC EDGAR.